OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI
Benjamin E. Peterson, Deepak L. Bhatt, Philippe Gabríel Steg, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 6
Open Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease
Aishwarya Krishnaraj, Ehab Bakbak, Hwee Teoh, et al.
Med (2023) Vol. 4, Iss. 2, pp. 130-138.e1
Open Access | Times Cited: 3

Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?
Marius Chukwurah, Michael Miller
Current Cardiology Reports (2023) Vol. 25, Iss. 9, pp. 987-992
Closed Access | Times Cited: 3

Marine-derived n-3 fatty acids therapy for stroke
Celia Gabriela Alvarez Campano, Mary Joan MacLeod, Lorna Aucott, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 3

Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome
Subodh Verma, Andrew Kosmopoulos, Deepak L. Bhatt, et al.
American Journal of Preventive Cardiology (2023) Vol. 15, pp. 100510-100510
Open Access | Times Cited: 1

Assessing Health and Economic Benefits of Omega-3 Fatty Acid Supplementation on Cardiovascular Disease in the Republic of Korea
Moon Seong Kim, Jin‐Man Kim, Sang Gyeong Lee, et al.
Healthcare (2023) Vol. 11, Iss. 16, pp. 2365-2365
Open Access | Times Cited: 1

Fish Oil Derivatives in Hypertriglyceridemia: Mechanism and Cardiovascular Prevention: What Do Studies Say?
Muhammed İbrahim Erbay, Norma Nicole Gamarra‐Valverde, Parth Patel, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102066-102066
Closed Access | Times Cited: 1

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
Zhipeng Zhang, Wei Xing, Jing Wei, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 1

Pharmacology
Abdalla Ammar, Kent A. Owusu
Springer eBooks (2024), pp. 397-416
Closed Access

Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus
Arnaud Planchat, Bariş Gencer, Sophie Degrauwe, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access

Icosapento de etilo en la disminución del riesgo residual. Nuevas evidencias
Leopoldo Pérez de Isla, Adriana Saltijeral Cerezo
Revista Española de Cardiología Suplementos (2023) Vol. 23, pp. 15-19
Open Access

O papel do ômega 3 na saúde vascular
André Matheus Carvalho Silva Leite, Bárbara Costa Cotrim, Caliane Luisa Pereira, et al.
Brazilian Journal of Implantology and Health Sciences (2023) Vol. 5, Iss. 5, pp. 3991-4000
Open Access

Previous Page - Page 2

Scroll to top